跳转至内容

We are planning system-wide maintenance between Oct 11, 4:30 AM and Oct 12, 10:30 AM CDT. It will impact both web and offline transactions, including online orders, quotes, price and availability checks, and order status inquiries. We apologize for any inconvenience.

Merck
CN

主要文件

查看所有文档

跳至

907294

Sigma-Aldrich

Fmoc-L-Photo-Phe-OH

≥95%

别名:

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)propanoic acid, N-α-(9-Fluorenylmethyloxycarbonyl)-4-(trifluoromethyldiazirin)-L-phenylalanine, Diazirine amino acid, Fmoc-Tdf-OH, Photo-Phe, Photo-crosslinking amino acid, Photoprobe building block

登录查看公司和协议定价

选择尺寸

变更视图
50 MG
CN¥4,567.38

关于此项目

经验公式（希尔记法）:
C26H20F3N3O4
化学文摘社编号:
133342-64-0
分子量:
495.45
MDL编号:
MFCD30187628
UNSPSC代码:
12352209
NACRES:
NA.22

CN¥4,567.38

请联系客服了解存货情况
获取大包装/定制包装报价
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

≥95%

表单

powder

反应适用性

reaction type: Fmoc solid-phase peptide synthesis

应用

peptide synthesis

官能团

Fmoc

储存温度

−20°C

SMILES字符串

FC(F)(F)C5(N=N5)c1ccc(cc1)C[C@H](NC(=O)OCC2c3c(cccc3)c4c2cccc4)C(=O)O

InChI

1S/C26H20F3N3O4/c27-26(28,29)25(31-32-25)16-11-9-15(10-12-16)13-22(23(33)34)30-24(35)36-14-21-19-7-3-1-5-17(19)18-6-2-4-8-20(18)21/h1-12,21-22H,13-14H2,(H,30,35)(H,33,34)/t22-/m0/s1

InChI key

UHXIAQUVGJCYSA-QFIPXVFZSA-N

相关类别

比较类似商品

查看完整比较结果

显示差异

1 of 1

此商品
907340907367907324
Fmoc-L-Photo-Phe-OH ≥95%

Sigma-Aldrich

907294

Fmoc-L-Photo-Phe-OH

H-L-Photo-Phe-OH ≥98%

Sigma-Aldrich

907340

H-L-Photo-Phe-OH

Fmoc-L-photo-methionine ≥95%

Sigma-Aldrich

907367

Fmoc-L-photo-methionine

Fmoc-L-photo-proline ≥95%

Sigma-Aldrich

907324

Fmoc-L-photo-proline

form

powder

form

powder

form

powder

form

powder

assay

≥95%

assay

≥98%

assay

≥95%

assay

≥95%

functional group

Fmoc

functional group

-

functional group

Fmoc

functional group

Fmoc

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

reaction suitability

reaction type: solution phase peptide synthesis

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

application(s)

peptide synthesis

application(s)

peptide synthesis

application(s)

peptide synthesis

application(s)

peptide synthesis

应用

Fmoc-L-Photo-Phe-OH is a diazirine-containing, Fmoc-protected phenylalanine amino acid and multifunctional photo-crosslinker. Its incorporation into peptides or small-molecule probes and tools allows for photoaffinity labeling of cellular targets and protein-protein interactions upon UV light (∼360 nm) irradiation to form a covalent bond. This and other multifunctional probe building blocks will continue to accelerate drug discovery research for probing cellular mechanisms, target ID/validation, and understanding traditionally undruggable targets. An unprotected version is also available as 907340.

Product can be used with our line of photoreactors: Including Penn PhD (Z744035) & SynLED 2.0 (Z744080)

其他说明

Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif

Mode of Action of cGMP-dependent Protein Kinase-specific Inhibitors Probed by Photoaffinity Cross-linking Mass Spectrometry

Trifluoromethyldiazirine: an effective photo-induced cross-linking probe for exploring amyloid formation

Simple and Versatile Method for Tagging Phenyldiazirine Photophores

Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis

Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)

储存分类代码

11 - Combustible Solids

WGK

WGK 3

法规信息

新产品
此项目有

    • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

    如需帮助，请联系 客户支持

    已有该产品？

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Michiel A Leeuwenburgh et al.
    Organic letters, 8(8), 1705-1708 (2006-04-07)
    [reaction: see text] A novel solid-phase synthesis strategy toward succinylhydroxamate peptides, using an appropriately protected hydroxamate building block, is described. Rapid and efficient access is gained to amine-functionalized peptides, which can be decorated with, for instance, a fluorescent label. In
    Ryuto Kino et al.
    Bioorganic & medicinal chemistry letters, 25(15), 2972-2975 (2015-06-06)
    Inhibition of amyloid-β (Aβ) aggregation could be a drug development target for treating Alzheimer disease. Insufficient activity to inhibit aggregation, however, remains a key issue. Here, we report a covalent modifier-type aggregation inhibitor of Aβ, diazirine-equipped cyclo-KLVF(β-Ph)F (2). Due to
    Martijn W H Pinkse et al.
    The Journal of biological chemistry, 284(24), 16354-16368 (2009-04-17)
    The inhibitor peptide DT-2 (YGRKKRRQRRRPPLRKKKKKH) is the most potent and selective inhibitor of the cGMP-dependent protein kinase (PKG) known today. DT-2 is a construct of a PKG tight binding sequence (W45, LRKKKKKH, KI=0.8 microM) and a membrane translocating sequence (DT-6
    Dany Fillion et al.
    Journal of medicinal chemistry, 49(7), 2200-2209 (2006-03-31)
    A stereospecific convergent synthesis of N-[(9-fluorenyl)methoxycarbonyl]-p-[3-(trifluoromethyl)-3H-diazirin-3-yl]-l-phenylalanine (Fmoc-12, Fmoc-Tdf) and its incorporation into the C-terminal position of the angiotensin II (AngII) peptide to form (125)I[Sar(1),Tdf(8)]AngII ((125)I-13) is presented. This amino acid photoprobe is a highly reactive carbene-generating diazirine phenylalanine derivative that
    M Ploug et al.
    Biochemistry, 37(11), 3612-3622 (1998-04-02)
    Binding of urokinase-type plasminogen activator (uPA) to its cellular receptor (uPAR) renders the cell surface a favored site for plasminogen activation. Recently, a 15-mer peptide antagonist of the uPA-uPAR interaction, with an IC50 value of 10 nM, was identified using
    查看所有相关文献

    我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持